To date, pay-for-performance programs targeting the care of persons with chronic conditions have primarily been directed at physicians and provide an alternative to health plan-sponsored chronic disease management (DM) programs. Both approaches require similar infrastructure, and each has its own advantages and disadvantages for program implementation. Pay-for-performance programs use incentives based on patient outcomes; however, an alternative system might incorporate measures of structure and process. Using a conceptual framework, the authors explore the variation in 50 diabetes DM programs using data from the 2002 National Business Coalition on Health’s eValue8 Request for Information (RFI). The authors raise issues relevant to the assignment of accountability for patient outcomes to either health plans or physicians. They analyze the association betweenRFI scores measuring structures and processes, and HEDIS diabetes intermediate outcome measures. Finally, the strengths and weaknesses of using the RFI scores as an alternative metric for pay-for-performance programs are discussed.
American Diabetes Association. 2003. Standards of medical care for patients with diabetes mellitus. Diabetes Care26 (Suppl. 1): S33-S50.
2.
Anderson, G., and J. Horvath. 2004. The growing burden of chronic disease in America. Public Health Reports119 (May/June): 263-270.
3.
Beich, J.2005. Diabetes care improvement initiatives in managed care organizations. University Park: Health Policy and Administration, Pennsylvania State University. http://etda.libraries.psu.edu/theses/approved/WorldWideIndex/ETD-1022/
4.
Bridges to Excellence. 2005. Bridges to excellence: Overview. http://www.bridgestoexcellence.org/bte/bte_overview.htm (accessed August 3, 2005).
5.
Centers for Disease Control and Prevention. 2004. National diabetes fact sheet: General information and national estimates on diabetes in the United States 2003. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/pubs/estimates.htm%23prev3 (accessed November 14, 2004).
6.
Couch, J. B.1998. Disease management: An overview. In The health care professional’s guide to disease management, edited by J. B. Couch. Gaithersburg, MD: Aspen.
7.
Cousins, M. S., L. M. Shickle, and J. A. Bander. 2002. An introduction to predictive modeling for disease management risk stratification. Disease Management5 (3): 3-27.
8.
Disease Management Association of America. 2002. DMAA definition of disease management. http://www.dmaa.org/definition.html (October 29, 2002).
9.
Everitt, B. S., S. Landau, and M. Leese. 2001. Cluster analysis. 4th ed.London: Arnold.
10.
Ferman, J. H.2004. Pay for performance gaining popularity. Healthcare Executive19 (4): 50-52.
11.
Fireman, B., J. Bartlett, and J. Selby. 2004. Can disease management reduce health care costs by improving quality?Health Affairs (Millwood)23 (6): 63-75.
12.
Glasgow, R. E., M. M. Funnell, A. E. Bonomi, C. Davis, V. Beckham, and E. H. Wagner. 2002. Self-management aspects of the improving chronic illness care breakthrough series: Implementation with diabetes and heart failure teams. Annals of Behavioral Medicine24 (2): 80-87.
13.
Institute for Clinical Systems Improvement. 2001. Management of Type 2 diabetes mellitus. http://www.icsi.org/knowledge/detail.asp?catID=29&itemID=182 (accessed February 14, 2003).
14.
Institute of Medicine. 2000. To err is human: Building a safer health system. Washington, DC: National Academy Press.
15.
Institute of Medicine. 2001. Crossing the quality chasm: Anew health system for the 21st century. Washington, DC: National Academy Press.
16.
Joint Commission on Accreditation of Healthcare Organizations. 2002. Disease-specific care certification manual. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations.
17.
Kaiser Family Foundation. 2004. Trends and indicators in the changing health care marketplace. http://www.kff.org/insurance/7031/index.cfm (accessed November 22, 2004).
18.
Larme, A. C., and J. A. Pugh. 1998. Attitudes of primary care providers toward diabetes: Barriers to guideline implementation. Diabetes Care21 (9): 1391-1396.
19.
McGlynn, E. A., S. M. Asch, J. Adams, J. Keesey, J. Hicks, A. DeCristofaro, and E. A. Kerr. 2003. The quality of health care delivered to adults in the United States. New England Journal of Medicine348 (26): 2635-2645.
20.
Metzger, J.2004. Using computerized registries in chronic disease management. Oakland: California Healthcare Foundation.
21.
National Committee for Quality Assurance. 2001. 2002 disease management standards and guidelines for accreditation. Washington, DC: National Committee for Quality Assurance.
22.
National Committee for Quality Assurance. 2003. The state of health care quality. http://www.ncqa.org/sohc2003/comprehensive_diabetes_care.htm (accessed November 22, 2004).
23.
Neuendorf, K. A.2002. The content analysis guidebook. Thousand Oaks, CA: Sage.
24.
Norris, S. L., M. M. Engelgau, and K. M. Narayan. 2001. Effectiveness of self-management training in Type 2 diabetes: Asystematic review of randomized controlled trials. Diabetes Care24 (3): 561-587.
25.
Rosenthal, M. B., R. Fernandopulle, H. R. Song, and B. Landon. 2004. Paying for quality: Providers’ incentives for quality improvement. Health Affairs (Millwood)23 (2): 127-141.
26.
Shojania, K. G., and J. M. Grimshaw. 2005. Evidence-based quality improvement: The state of the science. Health Affairs (Millwood)24 (1): 138-150.
27.
Shojania, K. G., K. M. McDonald, R.M. Wachter, and D.K. Owens. 2004. Closing the quality gap: A critical analysis of quality improvement strategies. Volume 2. Diabetes mellitus care. Stanford University-UCSF Evidence-based Practice Center. http://www.ahrq.gov/downloads/pub/evidence/pdf/qualgap/front.pdf (accessed March 5,2005).
28.
Stone, E. G., S. C. Morton, M. E. Hulscher, M. A. Maglione, E. A. Roth, J. M. Grimshaw, B. S. Mittman, L. V. Rubenstein, L. Z. Rubenstein, and P. G. Shekelle. 2002. Interventions that increase use of adult immunization and cancer screening services: A meta-analysis. Annals of Internal Medicine136 (9): 641-651.
29.
URAC. 2002. Accreditation program guide for disease management standards: Version 1. Washington, DC: URAC.
30.
Villagra, V.2004. Strategies to control costs and quality: A focus on outcomes research for disease management. Medical Care42 (4, Suppl.): III24-III30.
31.
Villagra, V., and T. Ahmed. 2004. Effectiveness of a disease management program for patients with diabetes. Health Affairs23 (4): 255-266.
32.
Wagner, E. H., B. T. Austin, C. Davis, M. Hindmarsh, J. Schaefer, and A. Bonomi. 2001. Improving chronic illness care: Translating evidence into action. Health Affairs20 (6): 64-78.
33.
Wagner, E. H., B. T. Austin, and M. Von Korff. 1996. Organizing care for patients with chronic illness. Milbank Quarterly74 (4): 511-544.
34.
Weingarten, S. R., and G. Graber. 1998. Outcome-validated clinical practice guidelines: A scientific foundation for disease management. In The health professional’s guide to disease management, edited by J. B. Couch. Gaithersburg, MD: Aspen.
